The initial discovery of the non-coding mutations within DPH3 promoter through exome sequencing followed by a screening of 586 different skin cancer lesions showed that those promoter mutations occurred not only in 10 percent of melanoma but were also present at a frequencies of 42 percent in BCC and 39 percent in SCC. The gene discussed is DPH3; the disease is skin cancer.